Combative  ||| S:0 E:10 ||| JJ
HF-rTMS  ||| S:10 E:18 ||| JJ
treatment ||| S:18 E:27 ||| NN
,  ||| S:27 E:29 ||| ,
for  ||| S:29 E:33 ||| IN
a  ||| S:33 E:35 ||| DT
bipolar  ||| S:35 E:43 ||| JJ
I  ||| S:43 E:45 ||| NN
patient ||| S:45 E:52 ||| NN
,  ||| S:52 E:54 ||| ,
following  ||| S:54 E:64 ||| VBG
unsuccessful  ||| S:64 E:77 ||| JJ
ECT  ||| S:77 E:81 ||| NN
We  ||| S:81 E:84 ||| PRP
aimed  ||| S:84 E:90 ||| VBD
to  ||| S:90 E:93 ||| TO
Examine  ||| S:93 E:101 ||| VB
the  ||| S:101 E:105 ||| DT
safety  ||| S:105 E:112 ||| NN
and  ||| S:112 E:116 ||| CC
effectiveness  ||| S:116 E:130 ||| NN
of  ||| S:130 E:133 ||| IN
HF-rTMS  ||| S:133 E:141 ||| JJ
in  ||| S:141 E:144 ||| IN
a  ||| S:144 E:146 ||| DT
treatment-refractory  ||| S:146 E:167 ||| JJ
bipolar  ||| S:167 E:175 ||| NN
I  ||| S:175 E:177 ||| PRP
patient  ||| S:177 E:185 ||| VBD
in  ||| S:185 E:188 ||| IN
a  ||| S:188 E:190 ||| DT
mixed  ||| S:190 E:196 ||| JJ
affective  ||| S:196 E:206 ||| JJ
episode ||| S:206 E:213 ||| NN
.  ||| S:213 E:215 ||| .
Our  ||| S:215 E:219 ||| PRP$
case  ||| S:219 E:224 ||| NN
illustrates  ||| S:224 E:236 ||| VBZ
that  ||| S:236 E:241 ||| DT
combative  ||| S:241 E:251 ||| JJ
HF-rTMS  ||| S:251 E:259 ||| JJ
therapy  ||| S:259 E:267 ||| NN
could  ||| S:267 E:273 ||| MD
be  ||| S:273 E:276 ||| VB
a  ||| S:276 E:278 ||| DT
safe  ||| S:278 E:283 ||| JJ
and  ||| S:283 E:287 ||| CC
valid  ||| S:287 E:293 ||| JJ
treatment  ||| S:293 E:303 ||| NN
alternative  ||| S:303 E:315 ||| NN
for  ||| S:315 E:319 ||| IN
refractory  ||| S:319 E:330 ||| JJ
bipolar  ||| S:330 E:338 ||| JJ
I  ||| S:338 E:340 ||| NN
patients  ||| S:340 E:349 ||| NNS
in  ||| S:349 E:352 ||| IN
mixed  ||| S:352 E:358 ||| JJ
episode ||| S:358 E:365 ||| NN
,  ||| S:365 E:367 ||| ,
not  ||| S:367 E:371 ||| RB
successfully  ||| S:371 E:384 ||| RB
treated  ||| S:384 E:392 ||| VBN
with  ||| S:392 E:397 ||| IN
ECT ||| S:397 E:400 ||| NNP
.  ||| S:400 E:402 ||| .
